Latest filing published 10 Apr 2026 for Monte Rosa Therapeutics, Inc., €88k.
Filing timeline
BuySaleInsider track record
Philip Nickson: trading record in brief
All filings by Philip Nickson on record concern Monte Rosa Therapeutics, Inc. Over a trading history stretching from 2 January 2025 to 9 April 2026, the count stands at 4 filings.
Every open-market trade on record is a sale: 2 sales worth €129k. Outside the open market, there are 2 share grants. In 2026 alone, the filings show no purchases and 2 sales.
On 10 April 2026 came the latest disclosure, an open-market sale for €88k in Monte Rosa Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Philip Nickson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,845 shares@ US$17.6925100.0% of flowCommon StockSEC:0001193125-26-151254:0
- 3,155 shares@ US$15.1731.6% of flowCommon StockSEC:0001193125-26-002406:1
- 28,000 sharesCommon StockSEC:0001193125-26-002406:0
- 36,000 sharesCommon StockSEC:0000950170-25-002105:0
4 of 4 declarations
